Delivery Order SPE2DB22D3501-SPE2DB24FUN57
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 27 mg tablets of the pharmaceutical product Methylphenidate ER. The $1,566.00 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, as well as an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 tablets of 36 mg extended-release methylphenidate. The $1,111.33 award has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) awarded by DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,998.07 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 100 packages of 36 mg methylphenidate extended-release tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to AmerisourceBergen Drug Corp, serving as the primary contract vehicle for the company to provide...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,605,231 tablets of 36 mg Methylphenidate ER (extended-release). The contract has a completion date of February 9, 2024 and a potential value of $1,547.85. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a maximum potential...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 27 mg extended-release methylphenidate tablets. The contract, valued at $2,639.49, has a period of performance through March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. In addition, AmerisourceBergen Drug Corp holds an indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,043,749 units of 18 mg methylphenidate extended-release tablets. The contract has a ceiling value of $1,780.00 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award, which does not have a set-aside designation....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $6,062.88 order is for the supply of 100 units of 18mg methylphenidate extended-release tablets. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the prime contractor's primary vehicle for providing...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,512,599 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,263.10 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $1,063.86 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 100 units of 36 mg methylphenidate extended release tablets. The contract has a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for providing pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation, to provide 4,563,502,027 units of Methylphenidate ER 27 mg tablets. The $3,090.10 contract has a completion date of February 1, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which was not set aside for any specific business type. The company also...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUN57Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide a 100-count supply of 54 mg methylphenidate extended release tablets. The contract, valued at $3,218.12, has a completion date of February 13, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which serves as the primary vehicle for the company to supply pharmaceuticals and medical supplies to support Department of Defense military treatment programs and facilities worldwide. The IDC does not have a set-aside designation and was awarded solely to Amerisourcebergen Drug Corp.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 2/12/24 |